Experts praise groundbreaking results from therapy using genetically modified Car T-cells
Cancer patients treated with a pioneering immunotherapy that genetically modifies their own cells to wipe out tumours live 40% longer, according to “exciting” and “groundbreaking” results from a world-first clinical trial.
Car T-cell therapy is a new form of immunotherapy where a patient’s own T-cells – a type of white blood cell – are tweaked in a lab to target and kill cancer cells. The designer cells are then infused back into their bloodstream to fight the disease.
About Author
More Stories
23andMe’s founder wins bid to regain control of bankrupt DNA testing firm
European journalists targeted with Paragon Solutions spyware, say researchers
UK-wide drug trial hailed as a ‘milestone’ in leukaemia treatment